Boston Scientific Corp. (BSX) Social Stream
BOSTON SCIENTIFIC CORP (BSX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BSX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-01 | 15 | $55 | $45 | $50.733 | $43.89 | 15.59% |
| 2021-12-13 | 16 | $55 | $45 | $50.75 | $43.89 | 15.63% |
| 2022-01-24 | 15 | $53 | $45 | $50.533 | $43.89 | 15.14% |
| 2022-02-01 | 15 | $53 | $45 | $50.4 | $43.89 | 14.83% |
| 2022-02-04 | 15 | $53 | $45 | $49.2 | $43.89 | 12.1% |
| 2022-02-15 | 15 | $53 | $45 | $49.428 | $43.89 | 12.62% |
| 2022-04-01 | 16 | $55 | $45 | $49.8 | $43.89 | 13.47% |
| 2022-04-11 | 16 | $55 | $45 | $49.666 | $43.89 | 13.16% |
| 2022-04-13 | 16 | $55 | $45 | $49.866 | $43.89 | 13.62% |
| 2022-04-29 | 15 | $55 | $45 | $49.928 | $43.89 | 13.76% |
| 2022-05-17 | 15 | $55 | $45 | $50 | $43.89 | 13.92% |
| 2022-05-27 | 14 | $55 | $45 | $49.6 | $43.89 | 13.01% |
| 2022-06-15 | 13 | $51 | $45 | $49.142 | $43.89 | 11.97% |
| 2022-07-27 | 15 | $51 | $43 | $47.411 | $43.89 | 8.02% |
| 2022-07-29 | 15 | $51 | $40 | $47.294 | $43.89 | 7.76% |
| 2022-08-24 | 14 | $51 | $43 | $47.705 | $43.89 | 8.69% |
| 2022-09-28 | 14 | $51 | $43 | $47.882 | $43.89 | 9.1% |
| 2022-10-11 | 15 | $51 | $43 | $47.812 | $43.89 | 8.94% |
| 2022-10-14 | 15 | $51 | $43 | $47.941 | $43.89 | 9.23% |
| 2022-10-17 | 15 | $51 | $43 | $47.882 | $43.89 | 9.1% |
| 2022-10-26 | 16 | $51 | $43 | $47.944 | $43.89 | 9.24% |
| 2022-11-10 | 16 | $51 | $43 | $48.111 | $43.89 | 9.62% |
| 2022-11-14 | 16 | $51 | $43 | $48.388 | $43.89 | 10.25% |
The Trend in the Analyst Price Target
Over the past 30 months, BSX's average price target has gone up $4.56.
Over the past 48 weeks, BSX's average upside potential has been 17.71%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-24 | 15 | 53 | 45 | 50.533 | 42.66 | 18.46% |
| 2022-03-16 | 16 | 55 | 45 | 49.800 | 43.84 | 13.59% |
| 2022-04-11 | 16 | 55 | 45 | 49.714 | 44.22 | 12.42% |
| 2022-04-29 | 15 | 55 | 45 | 50.000 | 42.11 | 18.74% |
| 2022-09-23 | 14 | 51 | 43 | 47.882 | 38.90 | 23.09% |
BSX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.38 | 12 | 2 | 2 | 0 | 0 | 16 |
The Trend in the Broker Recommendations
Over the past 18 months, BSX's average broker recommendation rating improved by 0.37.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BSX as an investment opportunity.
- BSX has a greater number of analysts covering the stock than 3263.53% of Healthcare stocks.
- BSX has a lower variance in analysts' estimates than -265.86% of stocks in the large market cap category.
- In terms of how BOSTON SCIENTIFIC CORP fares relative to Healthcare stocks, note that its upside potential (average analyst target price relative to current price) is higher than 525.7% of that group.
- In the context of stocks in the large market cap category, BOSTON SCIENTIFIC CORP's average analyst price target is higher than 988.01% of them.
In the Medical Equipment industry, ABMD, SYK, and TFX are the three stocks most similar to BOSTON SCIENTIFIC CORP regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is BSX a Buy, Hold or Sell? See the POWR Ratings now!